Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Umedica is a prominent Indian pharmaceutical company focused on the development, manufacturing, and marketing of generic formulations. A part of the Amoli Group, the company maintains a strong international presence, exporting finished dosage forms to over 60 countries worldwide. Their manufacturing facilities in Vapi, India, hold prestigious approvals from regulatory bodies including the US FDA, EU GMP, and WHO-GMP. Umedica's diverse portfolio spans several therapeutic areas such as anti-infectives, cardiovascular, and central nervous system treatments. The company provides both branded generics and contract manufacturing services to global partners. They specialize in various dosage forms including injectables, tablets, capsules, and liquid orals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Umedica.